Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
about
Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingTargeting cancer stem cells by using the nanoparticlesMultiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiencyNanomedicine therapeutic approaches to overcome cancer drug resistanceStrategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and marketBiophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticlesEngineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitroTargeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves.Nanoparticle "switch-on" by tetrazine triggeringProtease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance.Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyProgress in aptamer-mediated drug delivery vehicles for cancer targeting and its implications in addressing chemotherapeutic challenges.Pluronics and MDR reversal: an update.Application of chitosan-based nanocarriers in tumor-targeted drug delivery.Gold nanoparticles prepared by laser ablation in aqueous biocompatible solutions: assessment of safety and biological identity for nanomedicine applications.Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.The two faces of FBW7 in cancer drug resistance.A nanoparticle formula for delivering siRNA or miRNAs to tumor cells in cell culture and in vivo.Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups.Albumin and Hyaluronic Acid-Coated Superparamagnetic Iron Oxide Nanoparticles Loaded with Paclitaxel for Biomedical Applications.Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.Utilisation of nanoparticle technology in cancer chemoresistance.Odyssey of a cancer nanoparticle: from injection site to site of action.Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot studyCPMV-DOX delivers.Key structure of brij for overcoming multidrug resistance in cancerCancer stem cell theory: therapeutic implications for nanomedicine.Overcoming doxorubicin resistance of cancer cells by Cas9-mediated gene disruption.Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.DNA nanotechnology: a future perspective.Understanding and targeting cancer stem cells: therapeutic implications and challenges.A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.Potential of magnetic nanoparticles for targeted drug deliveryTargeting Cancer Stem Cells with Nanoparticle-Enabled Therapies.Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors.
P2860
Q26778234-2E81EDAC-0236-4E4A-BA11-D23A85B2F47DQ26783590-C6A41F5C-5CA0-4F3D-8325-F18D13C8B43DQ26827999-C127831D-39B5-4E5D-B557-8F0652B0959BQ27011692-D22CA222-1B7F-4A4B-A412-4553C0E7E97BQ27015050-1B810CD8-A3BE-4F61-BBA1-1BAD8CAFE6DEQ27026080-ACA835F8-2D26-4508-A661-5CD2B58F1F68Q28073956-14760A58-6AC6-4838-896A-3D9D8EEC7BF7Q28078448-9376521C-3724-4BC0-B9A1-1E9432E126A0Q28488394-06F35EE4-7284-490F-B24F-E65F7ABC593EQ28555163-238DE504-F4F1-42C3-8D49-C9FF4977D925Q28822555-6B9E1F7F-750E-422D-A5D8-7DC670C8FCC2Q30355600-BE100349-2D2E-4921-AD2D-B47EA7CF25A4Q30414688-20D7E988-CD0E-494B-A1DD-1EE22E472DA5Q33634653-859F758C-D63F-46C5-B734-685AE74B5CFAQ33859472-5BB52BA3-17D5-45D1-97E2-B1C50B190B51Q33935498-8125AD59-5EAD-43D4-8837-14ACC7D532AAQ34005678-51342ED8-B236-4758-9607-2A82FE790686Q34447152-1BDF97DA-1157-45E9-8388-30EFC9147380Q34584366-43D72CE7-5264-432F-9785-96A039511FE8Q35898159-0DB0423F-8524-4CB6-97D9-58FE5D595927Q35924301-3F884B3E-0191-443C-9A4F-34C10B9C2FC6Q35999467-B50FC3A8-F664-432C-9FC8-C2826389E379Q36061347-9710FDE6-E3A4-4C0C-A3AC-D53E208ED1F8Q36161045-6321F734-D295-42E2-86A5-7B7B4F3FC01CQ36412229-6B72A63C-CCB5-4811-982B-24C991974FD1Q36412928-4A21EA85-0271-4C64-9E4D-0BA0BD0E3EF4Q36421258-497EC6E0-79C5-4076-AF0A-24A6BDCEF27DQ36459196-3553E08F-25D7-4494-A06B-F389CF86FB5EQ36585890-8DF48EE4-EF1D-433E-9F38-F8922B1B401FQ36588240-2C96F535-CBBA-467A-9A59-5D7441BEA34AQ36615913-9CD9F972-8D7C-4D27-B979-F2CB75B41174Q36659443-860AB7C9-9AEE-4838-82EB-B537326834F9Q36670889-7281AE85-C5E4-419A-8860-0BF03F7106FAQ36680180-E862FDED-1056-4D57-BDC6-3C08E877C2B9Q36690125-F0C7F68C-80EC-493B-BD50-BE037451C120Q36907405-670FBC6A-C8D5-4925-B92D-ED38A012401EQ36951434-5D83411C-28E2-4E74-8119-C2FA5275839DQ37194054-C426E417-1583-46AD-84EE-050B26C2377FQ37419338-A381CBC6-1B7C-4428-A164-0411C0A58AC3Q37525035-B7AACEA2-893C-43F9-AD3D-63A42DB08087
P2860
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
@en
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
@nl
type
label
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
@en
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
@nl
prefLabel
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
@en
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
@nl
P2093
P1476
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance
@en
P2093
Alina Shapira
Henk J Broxterman
Yehuda G Assaraf
P304
P356
10.1016/J.DRUP.2011.01.003
P577
2011-02-16T00:00:00Z